|
T5841 |
Travoprost
|
Flu-Ipr,Fluprostenol isopropyl ester,AL6221 |
Prostaglandin Receptor
|
|
Travoprost (Fluprostenol isopropyl ester) is used to treat glaucoma and ocular hypertension,is a potent and selective FP prostaglandin receptor agonist. |
|
T21224 |
(+)-Fluprostenol
|
Fluprostenol, (+)-,Travoprost acid,AL-5848 |
Prostaglandin Receptor
|
|
(+)-Fluprostenol (AL-5848), an analogue of prostaglandin F2 alpha, is a prostaglandin F2α receptor PTGFR agonist and decreases the expression of Oviductal glycoprotein 1 (OVGP1). |
|
T37813 |
Fluprostenol methyl ester
|
|
|
|
Fluprostenol is an F-series prostaglandin analog which has been approved for many years as a luteolytic in veterinary animals. The isopropyl ester of fluprostenol (travoprost) is an effective ocular hypotensive drug. CAY... |
|
T37946 |
17-trifluoromethylphenyl trinor Prostaglandin F2α
|
17-trifluoromethylphenyl trinor Prostaglandin F2α |
|
|
A number of 17-phenyl trinor prostaglandin F2α (17-phenyl trinor PGF2α) derivatives have been approved for the treatment of glaucoma. Of these, the unsubstituted or meta-substituted aromatic derivatives are the most pote... |
|
T37777 |
17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide
|
17-trifluoromethylphenyl trinor Prostaglandin F2α ethyl amide |
|
|
Prostaglandin F2α (PGF2α), acting through the FP receptor, causes smooth muscle contraction and exhibits potent luteolytic activity. 17-trifluoromethylphenyl trinor Prostaglandin F2α (17-trifluoromethylphenyl trinor PGF2... |
|
T37948 |
17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α
|
17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α |
|
|
A number of 17-phenyl trinor prostaglandin F2α(17-phenyl trinor PGF2α) derivatives have been approved for the treatment of glaucoma.1,2,3Of these, the ones wherein the 13,14-double bond has been hydrogenated retain relat... |
|
T37947 |
17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester
|
17-trifluoromethylphenyl trinor Prostaglandin F2α methyl ester |
|
|
Prostaglandin F2α (PGF2α), acting through the FP receptor, causes smooth muscle contraction and exhibits potent luteolytic activity. 17-trifluoromethylphenyl trinor PGF2α is an analog of PGF2α that shares the meta-triflu... |
|
T37724 |
Lumula
|
|
|
|
There are currently four prostaglandin (PG) derivatives which have been approved for human clinical use for the treatment of glaucoma. The names of the PGs and the concentrations of the approved doses are: travoprost (40... |
